Invention Grant
- Patent Title: Use of EPA and DHA in secondary prevention
- Patent Title (中): 使用EPA和DHA进行二次预防
-
Application No.: US10979751Application Date: 2004-11-02
-
Publication No.: US08729124B2Publication Date: 2014-05-20
- Inventor: Philip Calder , Robert Grimble , Patrick Gallagher , Cliff Shearman
- Applicant: Philip Calder , Robert Grimble , Patrick Gallagher , Cliff Shearman
- Applicant Address: NO Baerum
- Assignee: Pronova Biopharma Norge AS
- Current Assignee: Pronova Biopharma Norge AS
- Current Assignee Address: NO Baerum
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P.
- Priority: GB0210212.7 20020305; GB0307625.4 20030204
- Main IPC: A61K31/202
- IPC: A61K31/202 ; A61K31/232
Abstract:
The invention is directed to a method for preventing cerebral damage in patients having symptoms of atherosclerosis of arteries supplying the brain by administering to the patient a therapeutically effective amount of a composition comprising eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) or a combination thereof.
Public/Granted literature
- US20050171200A1 Use of EPA and DHA in secondary prevention Public/Granted day:2005-08-04
Information query
IPC分类:
